000 01411 a2200385 4500
005 20250517025719.0
264 0 _c20150615
008 201506s 0 0 eng d
022 _a1558-318X
024 7 _a10.1016/j.ucl.2015.02.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPremo, Christopher
245 0 0 _aTrimodality therapy in bladder cancer: who, what, and when?
_h[electronic resource]
260 _bThe Urologic clinics of North America
_cMay 2015
300 _a169-80, vii p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Intramural; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aChecklist
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aCystectomy
650 0 4 _aHumans
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm Staging
650 0 4 _aOrgan Sparing Treatments
_xmethods
650 0 4 _aPatient Selection
650 0 4 _aRadiotherapy, Image-Guided
650 0 4 _aRadiotherapy, Intensity-Modulated
650 0 4 _aUrinary Bladder Neoplasms
_xpathology
700 1 _aApolo, Andrea B
700 1 _aAgarwal, Piyush K
700 1 _aCitrin, Deborah E
773 0 _tThe Urologic clinics of North America
_gvol. 42
_gno. 2
_gp. 169-80, vii
856 4 0 _uhttps://doi.org/10.1016/j.ucl.2015.02.002
_zAvailable from publisher's website
999 _c24813122
_d24813122